Health Highlights: Oct. 2, 2019
Here are some of the latest health and medical news developments, compiled by the editors of HealthDay:
Juul Halts Funding For San Francisco Vaping Ballot Initiative
On Monday, San Francisco-based Juul Labs Inc. said it will no longer fund an effort to quash an anti-vaping law in the city, effectively ending the campaign.
Juul, the largest maker of e-cigarettes, is ending support for the measure after giving nearly $19 million, according to the Associated Press.
Juul's decision follows closely on major changes at the company, including replacing its CEO.
The proposition, however, will still be on the ballot in November.
The law, called proposition C, would permit the sale of vaping products to adults. If it passes, it would override a law passed in June banning the sale of any e-cigarette that has not been reviewed by the U.S. Food and Drug Administration.
"This could very well be yet another of a series of lies and exaggerations from Juul and Big Tobacco," Larry Tramutola, who directs the No on Prop C campaign said in a statement.
"Until they return the $7 million unspent dollars that is in their political account, until they suspend their mail, their advertising, their paid phone calls and lay off their consultants, we do not believe them," he said.
© 2020 HealthDay. All rights reserved.
Posted: October 2019
Read this next
THURSDAY, Oct. 22, 2020 -- "Heat-not-burn" tobacco products, created as an alternative to other types of smoking, may harm the user's heart, researchers report. These tobacco...
WEDNESDAY, Oct. 14, 2020 -- The purported link between e-cigarettes and lung damage might be more complicated than first thought, a new study reports. Teen e-cigarette users are...
THURSDAY, Oct. 8, 2020 -- The type of heating coil used in an e-cigarette and the amount of voltage sent through it could be contributing to vaping-related lung injuries, a new...
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
- Monthly Update Archive
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.